Skip to content

Acetylcarnitine

Published: July 26, 2026Updated: August 27, 2026

Acetylcarnysteine is an naturally occurring compound and derivative of L-carnitine that plays a role in cellular energy metabolism and neurotransmitter function. It is classified as a nootropic and neuroprotective agent under ATC class N06 and is used primarily for neurological and cognitive health support.

Quick summary

Acetylcarnitine is a neuroprotective supplement used for cognitive support, nerve health, and mood regulation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ATC
unclassified
RxNorm
unknown
Generic
Acetylcarnitine
Class
atc-n06
Brands
—
Availability
otc
Pregnancy
B
Lactation
caution
Half-life (h)
3
Onset (min)
30
Duration (h)
6
Routes
oral
Forms
capsules, tablets, powder
Regions
US, EU, UK, CA, AU
Monitoring
none

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: No well-established toxic single dose reported in clinical literature
Chronic overdose: No clear chronic toxicity threshold established
Immediate actions
Supportive care, monitoring of vital signs, symptomatic treatment
Antidote
No specific antidote available(N/A - supportive care is mainstay of treatment)
Poison Control: 1-800-222-1222

Special Populations

12 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if clearly needed and benefits outweigh potential risks

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if clearly needed and benefits outweigh potential risks

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if clearly needed and benefits outweigh potential risks

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

lactation

breastfeeding
caution
FDA Category
N
Dose Adjustment

use with caution

Key Recommendations

monitor infant for adverse effects; consider temporary discontinuation

Monitor

observe infant for feeding problems, vomiting, diarrhea

Use with caution and monitor for adverse effects.

✓

geriatric

elderly 65 plus
safe
FDA Category
N
Dose Adjustment

no specific adjustment required

Key Recommendations

standard dosing; consider renal function

Monitor

monitor renal function periodically

⚠

pediatric_age

infants
caution
FDA Category
C
Dose Adjustment

weight-based dosing required

Key Recommendations

use only under medical supervision for metabolic disorders

Monitor

close monitoring of growth and development

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children 2 12 years
caution
FDA Category
C
Dose Adjustment

weight-based dosing required

Key Recommendations

use only under medical supervision; not for routine supplementation

Monitor

monitor growth parameters and adverse effects

Use with caution and monitor for adverse effects.

✓

renal_impairment

mild renal impairment
safe
FDA Category
N
Dose Adjustment

no adjustment needed

Key Recommendations

standard dosing; monitor renal function

Monitor

periodic renal function monitoring

⚠

renal_impairment

severe renal impairment
caution
FDA Category
N
Dose Adjustment

reduce dose and extend dosing interval

Key Recommendations

use lower dose; monitor for accumulation

Monitor

frequent renal function monitoring and drug levels if available

Use with caution and monitor for adverse effects.

✓

hepatic_impairment

mild hepatic impairment
safe
FDA Category
N
Dose Adjustment

no adjustment needed

Key Recommendations

standard dosing; monitor liver function

Monitor

periodic liver function tests

⚠

hepatic_impairment

severe hepatic impairment
caution
FDA Category
N
Dose Adjustment

reduce dose

Key Recommendations

use with caution; start with lower dose

Monitor

monitor liver function and clinical status

Use with caution and monitor for adverse effects.

✓

alcohol_users

chronic alcohol use
safe
FDA Category
N
Dose Adjustment

no specific adjustment

Key Recommendations

may provide benefit for alcohol-related liver disease and neuropathy

Monitor

monitor liver function tests

Statistics and clinical data

drug_classFDA
2023

Drug class

Value:Dietary supplement / Nootropic

Acetylcarnitine is regulated as a dietary supplement in the US

usageNational Institutes of Health
2023

Common therapeutic uses

Value:Cognitive support, neuropathic pain, fatigue, mitochondrial function

Common off-label and supplement uses based on clinical research

mechanismPubMed
2023

Primary mechanism

Value:Mitochondrial energy metabolism support, acetyl group donor

Known biochemical mechanisms of action

researchPubMed
2023

Extensive research since

Value:1980s

Publication history shows significant research interest beginning in the 1980s

Primarily used for cognitive support in age-related memory decline, peripheral neuropathy, and diabetic neuropathy. May also be used as adjunctive support in mood disorders and chronic fatigue. Sometimes utilized for supporting mitochondrial function in various neurological conditions.

Functions as a precursor to acetylcholine, supporting neurotransmitter synthesis. Facilitates fatty acid transport into mitochondria for energy production, particularly in neurons. Exhibits antioxidant properties and may support nerve regeneration through improved mitochondrial function and neuroprotection.

Generally well-tolerated with few side effects, though gastrointestinal symptoms may occur in some individuals. May interact with thyroid medications and anticoagulants. Should be used under medical supervision in patients with seizure disorders. Not recommended during pregnancy or breastfeeding without professional guidance.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy